Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabian Proft

Showing results (11-20 of 137) with videos related to

Pageof 14
Sort By:
Archives of Rheumatology|December 21, 2023
Beyond the horizon: Innovations and future directions in axial-spondyloarthritisVincenzo Venerito, Sergio Del Vescovo, Giuseppe Lopalco, et al.
Rheumatology Advances in Practice|April 21, 2025
AI for imaging evaluation in rheumatology: applications of radiomics and computer vision-current status, future prospects and potential challengesLina Xu, Keno Bressem, Lisa Adams, et al.
The Journal of Rheumatology|May 15, 2026
Advancing Psoriatic Disease Knowledge: Highlights From the GRAPPA 2025 Trainee SymposiumM Elaine Husni, Sibel Z Aydin, Fabian Proft, et al.
Expert Opinion on Biological Therapy|August 7, 2024
The management of axial spondyloarthritis with cutting-edge therapies: advancements and innovationsGiuseppe Lopalco, Andrea Cito, Vincenzo Venerito, et al.
RMD Open|January 8, 2024
Difficult-to-treat psoriatic arthritis (D2T PsA): a scoping literature review informing a GRAPPA research projectShikha Singla, Andre Ribeiro, Murat Torgutalp, et al.
Frontiers in Immunology|August 18, 2025
Beyond inflammation: the molecular basis of bone remodeling in axial spondyloarthritis and psoriatic arthritisGiuseppe Lopalco, Andrea Cito, Florenzo Iannone, et al.
Best Practice & Research. Clinical Rheumatology|April 12, 2026
Difficult to treat disease in psoriatic arthritis- is it different from axial spondyloarthritis?Jean-Guillaume Letarouilly, André L Ribeiro, Murat Torgutalp, et al.
Annals of the Rheumatic Diseases|December 11, 2019
Correspondence on: 'Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity?' by Wallman <i>et al</i>Fabian Proft, Mikhail Protopopov, Valeria Rios Rodriguez, et al.
BMJ Open|June 12, 2017
Study protocol: COmparison of the effect of treatment with Nonsteroidal anti-inflammatory drugs added to anti-tumour necrosis factor a therapy versus anti-tumour necrosis factor a therapy alone on progression of StrUctural damage in the spine over two years in patients with ankyLosing spondylitis (CONSUL) - an open-label randomized controlled multicenter trialFabian Proft, Burkhard Muche, Joachim Listing, et al.
Seminars in Arthritis and Rheumatism|May 13, 2014
Disease burden, disease manifestations and current treatment regimen of the SAPHO syndrome in Germany: results from a nationwide patient surveyMatthias Witt, Johanna Meier, Ariane Hammitzsch, et al.
Pageof 14

Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
Archives of Rheumatology|December 21, 2023
Beyond the horizon: Innovations and future directions in axial-spondyloarthritisVincenzo Venerito, Sergio Del Vescovo, Giuseppe Lopalco, et al.
Rheumatology Advances in Practice|April 21, 2025
AI for imaging evaluation in rheumatology: applications of radiomics and computer vision-current status, future prospects and potential challengesLina Xu, Keno Bressem, Lisa Adams, et al.
The Journal of Rheumatology|May 15, 2026
Advancing Psoriatic Disease Knowledge: Highlights From the GRAPPA 2025 Trainee SymposiumM Elaine Husni, Sibel Z Aydin, Fabian Proft, et al.
Expert Opinion on Biological Therapy|August 7, 2024
The management of axial spondyloarthritis with cutting-edge therapies: advancements and innovationsGiuseppe Lopalco, Andrea Cito, Vincenzo Venerito, et al.
RMD Open|January 8, 2024
Difficult-to-treat psoriatic arthritis (D2T PsA): a scoping literature review informing a GRAPPA research projectShikha Singla, Andre Ribeiro, Murat Torgutalp, et al.
Frontiers in Immunology|August 18, 2025
Beyond inflammation: the molecular basis of bone remodeling in axial spondyloarthritis and psoriatic arthritisGiuseppe Lopalco, Andrea Cito, Florenzo Iannone, et al.
Best Practice & Research. Clinical Rheumatology|April 12, 2026
Difficult to treat disease in psoriatic arthritis- is it different from axial spondyloarthritis?Jean-Guillaume Letarouilly, André L Ribeiro, Murat Torgutalp, et al.
Annals of the Rheumatic Diseases|December 11, 2019
Correspondence on: 'Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity?' by Wallman <i>et al</i>Fabian Proft, Mikhail Protopopov, Valeria Rios Rodriguez, et al.
BMJ Open|June 12, 2017
Study protocol: COmparison of the effect of treatment with Nonsteroidal anti-inflammatory drugs added to anti-tumour necrosis factor a therapy versus anti-tumour necrosis factor a therapy alone on progression of StrUctural damage in the spine over two years in patients with ankyLosing spondylitis (CONSUL) - an open-label randomized controlled multicenter trialFabian Proft, Burkhard Muche, Joachim Listing, et al.
Seminars in Arthritis and Rheumatism|May 13, 2014
Disease burden, disease manifestations and current treatment regimen of the SAPHO syndrome in Germany: results from a nationwide patient surveyMatthias Witt, Johanna Meier, Ariane Hammitzsch, et al.
Pageof 14